IL145995A0 - Use - Google Patents

Use

Info

Publication number
IL145995A0
IL145995A0 IL14599500A IL14599500A IL145995A0 IL 145995 A0 IL145995 A0 IL 145995A0 IL 14599500 A IL14599500 A IL 14599500A IL 14599500 A IL14599500 A IL 14599500A IL 145995 A0 IL145995 A0 IL 145995A0
Authority
IL
Israel
Application number
IL14599500A
Other languages
English (en)
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910166.9A external-priority patent/GB9910166D0/en
Priority claimed from GB0002113A external-priority patent/GB0002113D0/en
Application filed by Sterix Ltd filed Critical Sterix Ltd
Publication of IL145995A0 publication Critical patent/IL145995A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL14599500A 1999-04-30 2000-04-28 Use IL145995A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9910166.9A GB9910166D0 (en) 1999-04-30 1999-04-30 Use
US13952099P 1999-06-16 1999-06-16
GB0002113A GB0002113D0 (en) 2000-01-28 2000-01-28 Use
PCT/GB2000/001661 WO2000066095A2 (en) 1999-04-30 2000-04-28 Use of estrone derivatives as antitumour agents

Publications (1)

Publication Number Publication Date
IL145995A0 true IL145995A0 (en) 2002-07-25

Family

ID=27255503

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14599500A IL145995A0 (en) 1999-04-30 2000-04-28 Use
IL145995A IL145995A (en) 1999-04-30 2001-10-17 Use of cyclic compound in the manufacture of a medicament for the treatment of hormone independent cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145995A IL145995A (en) 1999-04-30 2001-10-17 Use of cyclic compound in the manufacture of a medicament for the treatment of hormone independent cancer

Country Status (7)

Country Link
US (1) US8207152B2 (https=)
EP (1) EP1173182A2 (https=)
JP (1) JP5042411B2 (https=)
AU (1) AU783910B2 (https=)
IL (2) IL145995A0 (https=)
NZ (1) NZ515061A (https=)
WO (1) WO2000066095A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US20020106348A1 (en) * 2000-07-12 2002-08-08 Peng Huang Cancer therapeutics involving the administration of 2-methoxyestradiol and an agent that increases intracellular superoxide anion
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents
EP1343803A2 (en) * 2000-11-27 2003-09-17 EntreMed, Inc. 2-substituted estrogens as antiangiogenic agents
GB0113920D0 (en) 2001-06-07 2001-08-01 Sterix Ltd Composition
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
DE10139494A1 (de) * 2001-08-13 2003-03-06 Jenapharm Gmbh Antitumor wirksame 2-Alkoxyestradiolsulfamate
ES2256576T3 (es) * 2001-12-21 2006-07-16 Schering Aktiengesellschaft Proceso aplicable industrialmente para la sulfamoilacion de alcoholes y fenoles.
GB0306717D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
PL378577A1 (pl) * 2003-03-24 2006-05-02 Sterix Limited Pochodne estrogenu jako inhibitory sulfatazy steroidowej
EP1633367A2 (en) 2003-05-28 2006-03-15 EntreMed, Inc. Antiangiogenic agents
CA2558014A1 (en) 2004-03-12 2005-09-29 Entremed, Inc. Antiangiogenic agents
GB0421106D0 (en) * 2004-09-22 2004-10-27 Sterix Ltd Compound
CA2646065C (en) 2006-03-20 2014-01-14 Entremed, Inc. Disease modifying anti-arthritic activity of 2-methoxyestradiol
EP4444318A4 (en) * 2021-12-06 2026-01-28 Amneal Pharmaceuticals Llc COMPOUNDS FOR CANCER TREATMENT

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
GB9603325D0 (en) 1996-02-16 1996-04-17 Imperial College A compound
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
GB9118465D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
ATE286038T1 (de) 1996-03-05 2005-01-15 Sterix Ltd Verbindungen mit sulfonsäure-amidgruppe
AU713341B2 (en) 1996-09-12 1999-12-02 Teikoku Hormone Mfg. Co., Ltd. 3-substituted-d-homo-1,3,5,(10)-estratriene derivatives
US5763492A (en) * 1996-10-01 1998-06-09 Duguesne University Of The Holy Ghost Methods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitors
US5880115A (en) 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
GB2331988B (en) * 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
GB2331987B (en) * 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
AU765386B2 (en) * 1998-06-10 2003-09-18 Sterix Limited Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-(o)-sulphamate for inhibition of estrone sulphatase
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
US20030086924A1 (en) * 1999-06-25 2003-05-08 Genentech, Inc. Treatment with anti-ErbB2 antibodies

Also Published As

Publication number Publication date
AU4766800A (en) 2000-11-17
AU783910B2 (en) 2005-12-22
NZ515061A (en) 2004-04-30
US8207152B2 (en) 2012-06-26
WO2000066095A2 (en) 2000-11-09
US20060122161A1 (en) 2006-06-08
JP5042411B2 (ja) 2012-10-03
JP2002543114A (ja) 2002-12-17
WO2000066095A3 (en) 2001-08-09
EP1173182A2 (en) 2002-01-23
IL145995A (en) 2009-11-18

Similar Documents

Publication Publication Date Title
GB9922662D0 (en) Handle-gripping
DE60027722D1 (en) Aspartyl-protease inhibitoren
IL145995A0 (en) Use
GB9913536D0 (en) Use
DE60036727D1 (en) Differentialverstärker
GB2352957B (en) Numnah
GB9915279D0 (en) Akettle
GB9912097D0 (en) E-Pen
DE50008218D1 (en) Common-rail-injektor
DE50012999D1 (en) Stirnwandisolation
GB9919971D0 (en) Use
DE60027883D1 (en) Photlithographieverfahren
GB9929772D0 (en) New use
GB9900064D0 (en) Weblok polyfloor
GB9914278D0 (en) Instantent
GB9910166D0 (en) Use
GB9915473D0 (en) New use
GB9930100D0 (en) New use
GB9928339D0 (en) New Use
GB9928329D0 (en) New use
GB9907261D0 (en) New use
GB9903282D0 (en) Novel use
GB9903284D0 (en) Novel use
GB9903265D0 (en) Novel use
GB9915469D0 (en) Novel use